2026-05-05T10:09:16Zhttps://uvadoc.uva.es/oai/requestoai:uvadoc.uva.es:10324/631592023-11-22T20:00:47Zcom_10324_40357com_10324_952com_10324_894col_10324_40358
Martínez Plaza, Elena
Molina Martín, Ainhoa
Piñero, David P.
2023-11-22T13:25:15Z
2023-11-22T13:25:15Z
2022
Applied Sciences, 2022, Vol. 12, Nº. 9, 4589
2076-3417
https://uvadoc.uva.es/handle/10324/63159
10.3390/app12094589
4589
9
Applied Sciences
12
2076-3417
The goal of this study was to analyze the agreement between the Medmont E300 and the Visionix VX120+ systems in terms of non-invasive tear break-up time (NIBUT) and tear meniscus height (TMH) measurements. A total of 60 eyes (30 healthy subjects) were enrolled. NIBUT and TMH were evaluated with Medmont E300; first NIBUT, NIBUT50%, and TMH were evaluated with Visionix VX120+. Both evaluations were performed in a random order by the same clinician for right, left, and both eyes. The Medmont E300 provided significantly higher NIBUT than Visionix VX120+ for first NIBUT in right, left, and both eyes (p ≤ 0.003) and NIBUT50% in left and both eyes (p ≤ 0.042). The TMH measured with VX120+ was significantly higher than with Medmont E300 considering both eyes (p = 0.037). No significant correlations were found between both devices for either NIBUT (p ≥ 0.11) or TMH (p ≥ 0.09). Passing–Bablok regression analyses revealed poor agreement between devices for NIBUT and TMH outcomes. VX120+ is expected to provide substantial lower first NIBUT values than the NIBUT measured by Medmont E300. Clinicians should consider not using both instruments as interchangeable for dry eye diagnosis.
eng
info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by/4.0/
© 2022 The Authors
Atribución 4.0 Internacional
Eye - Diseases - Treatment
Ojo - Enfermedades y defectos - Tratamiento
Dry eye syndromes
Síndrome de ojo seco
Ophthalmology
Materials science
Ciencia de los materiales
Medical technology
Agreement of tear break-up time and meniscus height between Medmont E300 and Visionix VX120+
info:eu-repo/semantics/article